133 related articles for article (PubMed ID: 29577096)
1. Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma.
Echegaray JJ; Llop S; Sepulveda M; Velez-Rosario R; Perez N; Oliver AL
Am J Ophthalmol Case Rep; 2018 Mar; 9():77-79. PubMed ID: 29577096
[TBL] [Abstract][Full Text] [Related]
2. A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma.
Svozílková P; Heissigerová J; Brichová M; Kalvodová B; Dvořák J; Ríhová E
Virol J; 2013 Jan; 10():18. PubMed ID: 23295015
[TBL] [Abstract][Full Text] [Related]
3. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
4. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
5. Use of intravitreal rituximab and methotrexate in vitreoretinal lymphoma.
Rahhal-Ortuño M; Udaondo-Mirete P; Fernández-Santodomingo AS; Díaz-Llopis M
Eur J Ophthalmol; 2022 Jan; 32(1):NP199-NP202. PubMed ID: 32985253
[TBL] [Abstract][Full Text] [Related]
6. Acute Sterile Endophthalmitis Following Intravitreal Rituximab Injection in Primary Vitreoretinal Lymphoma: Case Series.
Guneri Beser B; Demirci H
Ocul Immunol Inflamm; 2023 Mar; ():1-6. PubMed ID: 36952513
[TBL] [Abstract][Full Text] [Related]
7. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy.
Venkatesh P; Gogia V; Khanduja S; Gupta S; Kumar L; Garg S
J Cancer Res Ther; 2015; 11(3):668. PubMed ID: 26458712
[TBL] [Abstract][Full Text] [Related]
9. MACULAR HOLE FORMATION AFTER PARS PLANA VITRECTOMY FOR PRIMARY VITREORETINAL LYMPHOMA.
Haruta M; Taguchi C; Yamakawa R
Retin Cases Brief Rep; 2020; 14(3):243-246. PubMed ID: 29176526
[TBL] [Abstract][Full Text] [Related]
10. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
11. [Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin's lymphoma].
Fernández Cañabate E; Fernández-Cañabate S
Farm Hosp; 2018 Jan; 42(1):20-21. PubMed ID: 29306309
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of Primary Breast Lymphoma Presenting as Bilateral Vitreoretinal Lymphoma.
Habbu K; George R; Materin M
Ocul Oncol Pathol; 2021 Oct; 7(5):311-315. PubMed ID: 34722485
[TBL] [Abstract][Full Text] [Related]
13. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from India.
Rishi P; Manchegowda PT; Gondhale HP; Rishi E; Das K; Krishnakumar S; Raja T; Biswas J
Int Ophthalmol; 2021 Jul; 41(7):2495-2504. PubMed ID: 33730314
[TBL] [Abstract][Full Text] [Related]
15. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
Hasan N; Narde HK; Das AK; Chawla R
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy as Salvage Treatment in Intraocular Lymphoma: A Case Report.
Colaço R; Portela M; Costa I; Guedes M; Mota A
Case Rep Oncol; 2021; 14(1):184-189. PubMed ID: 33776701
[TBL] [Abstract][Full Text] [Related]
17. Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab.
Kakkassery V; Heindl LM; Rokohl AC; Chronopoulos A; Schutz JS; Ranjbar M; Schargus M; Böker A; Winterhalter S; Stübiger N
Neurosignals; 2021 May; 29(S1):1-7. PubMed ID: 33945240
[TBL] [Abstract][Full Text] [Related]
18. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
19. Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma.
Fan KC; Tran KD; Harbour JW; Dubovy SA; Patel NA; Albini TA
J Ophthalmic Inflamm Infect; 2019 Jun; 9(1):11. PubMed ID: 31183567
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
